猪源与牛源二尖瓣生物瓣膜耐久性比较
该研究比较了猪源与牛源支架生物瓣膜在二尖瓣置换术后的耐久性。2000至2024年间共纳入6,515例成人患者,经倾向性评分匹配后得到1,853对匹配组。结果显示猪源瓣膜因结构性瓣膜衰败(SVD)再干预的15年条件概率低于牛源瓣膜(34% vs 45%),且10年≥中度二尖瓣反流风险更低(3% vs 12%),平均跨瓣压差也更低(6.6 mmHg vs 8.2 mmHg)。
要点
- 猪源二尖瓣生物瓣膜15年SVD再干预条件概率34%,低于牛源瓣膜的45%
- 猪源瓣膜10年≥中度二尖瓣反流风险3%,显著低于牛源瓣膜的12%
- 牛源瓣膜平均跨瓣压差更高(8.2 mmHg vs 6.6 mmHg),尤其适用于60岁以下患者
核心结论
- 支架猪源生物瓣膜在二尖瓣位置耐久性优于牛源生物瓣膜,晚期结局良好,尤其适用于60岁以下患者。
研究设计与样本
- 回顾性队列研究,纳入2000年1月1日至2024年1月1日期间6,515例成人二尖瓣置换术患者,共6,789枚支架生物瓣膜(猪源n=4,597,牛源n=2,192),倾向性评分匹配后得到1,853对匹配组。
主要发现
- 匹配组中共识别352例再干预,主要因SVD(70%,n=253)和感染性心内膜炎(19%,n=69)。
- 15年SVD再干预条件概率猪源组34%,牛源组45%(早期P=.61;晚期P=.003)。
- 猪源组术后第一年感染性心内膜炎再干预风险增加(P=.046),此后风险相似(P=.54)。
- 10年≥中度二尖瓣反流风险猪源组3%,牛源组12%(P<.0001),牛源组平均跨瓣压差更高(6.6 mmHg vs 8.2 mmHg;晚期P<.0001)。
- 15年生存率猪源组18%,牛源组22%(P=.21)。
关键数值与推荐
- 15年SVD再干预条件概率:猪源34% vs 牛源45%(晚期P=.003)。
- 10年≥中度二尖瓣反流风险:猪源3% vs 牛源12%(P<.0001)。
- 平均跨瓣压差:猪源6.6 mmHg vs 牛源8.2 mmHg(晚期P<.0001)。
- 15年生存率:猪源18% vs 牛源22%(P=.21)。
临床怎么用
- 在二尖瓣位置选择支架生物瓣膜时,猪源瓣膜耐久性更优,可优先考虑,尤其对60岁以下患者。
- 牛源瓣膜术后晚期SVD和瓣膜反流风险更高,需加强超声随访监测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to compare the durability of bovine pericardial and porcine bioprostheses in patients who underwent surgical mitral valve replacement. METHODS: From 1/1/2000-1/1/2024, 6,515 adults underwent 6,789 mitral valve replacements with either porcine(n=4,597) or bovine(n=2,192) stented bioprostheses. Propensity score matching yielded 1,853 well-matched pairs. Durability was assessed by explant for structural valve deterioration(SVD) and longitudinal analysis of echocardiographic data(≥moderate mitral regurgitation and mean mitral gradient). Mortality and competing risks of explant for SVD and infective endocarditis were modeled using multiphase hazards. RESULTS: Bovine bioprostheses were more commonly used before 2010, and porcine more recently. Within the matched groups, 352 reinterventions were identified, primarily for SVD(70%; n=253) and endocarditis(19%; n=69). At 15 years, conditional probability of reintervention for SVD was 34% in the porcine versus 45% in the bovine group(early P=.61; late P=.003). The porcine group had an increased risk of reintervention for endocarditis in the first year(P=.046), but similar risk thereafter(P=.54). Risk of ≥moderate mitral regurgitation at 10 years was 3% among porcine and 12% among bovine bioprostheses(P<.0001), with higher mean gradients in the bovine group(6.6 mmHg vs. 8.2 mmHg; late P<.0001). Survival 15-years after porcine mitral valve replacement was 18%, compared to 22% after bovine(P=.21). CONCLUSIONS: The stent-mounted porcine bioprosthesis had better durability than the bovine bioprosthesis in the mitral position and is preferred over a bovine bioprosthesis with excellent late outcomes, particularly in patients under 60 years of age.
引用
- Malas T, Bakir NH, Poddi S, et al. Comparative Durability of Porcine and Bovine Mitral Valve Bioprostheses. J Thorac Cardiovasc Surg. 2026. PMID: 42854829. doi:10.1016/j.jtcvs.2026.09.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。